Last reviewed · How we verify
Glucose Monophosphate (glucose-1-phosphate)
Glucose Monophosphate (generic name: glucose-1-phosphate) is a glucose-1-phosphate drug. It is currently in unknown development.
Glucose-1-phosphate is thought to influence glucose metabolism.
Glucose-1-phosphate is a small molecule drug in the glucose-1-phosphate class, but information on its development, commercial status, and approved indications is not available. As a result, there is limited information on its target, half-life, bioavailability, and generic manufacturers. The mechanism of action of glucose-1-phosphate is not well-documented, but it is believed to work by influencing glucose metabolism. Further research is needed to fully understand its effects and potential applications. Unfortunately, without more information, it is difficult to provide a comprehensive summary of this compound.
At a glance
| Generic name | glucose-1-phosphate |
|---|---|
| Drug class | glucose-1-phosphate |
| Therapeutic area | Metabolic |
| Phase | unknown |
Mechanism of action
Glucose-1-phosphate is a molecule that plays a role in how our bodies use glucose, a type of sugar for energy. It helps regulate the flow of glucose into cells, which is important for maintaining healthy blood sugar levels. By influencing this process, glucose-1-phosphate may help treat conditions related to glucose metabolism.
Approved indications
Common side effects
Key clinical trials
- Effect of Hyperbaric Oxygen Therapy on Insulin Resistance in Postmenopausal Women (Phase 1)
- Does Insulin Sensitivity Impact the Potential of Metformin to Slow Aging (Phase 3)
- Clinical Study to Assess Entry of Chemotherapeutic Agents Into Brain Metastases in Women With Breast Cancer (N/A)
- A Preliminary Investigation of Individual Differences in Subjective Responses to D-amphetamine, Alcohol, and Delta-9-tetrahydrocannabinol (NA)
- Phase 3 Randomized Trial of Tadalafil and Glycemic Traits (Phase 3)
- Sorting of Oral Sensations (N/A)
- A Phase I Study to Determine the Pharmacokinetic Profile, Safety and Tolerability of Sildenafil (REVATIO®) in Cardiac Surgery (Phase 1)
- Measuring Inflammation Cells (CD163 and CD206) With the Purpose of Examining Reduction of Fibrosis in the Liver of Chronic Hepatitis C Patients Following Treatment With the Medication Sofosbuvir (N/A)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Glucose Monophosphate CI brief — competitive landscape report
- Glucose Monophosphate updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Glucose Monophosphate
What is Glucose Monophosphate?
How does Glucose Monophosphate work?
What is the generic name of Glucose Monophosphate?
What drug class is Glucose Monophosphate in?
What development phase is Glucose Monophosphate in?
Related
- Drug class: All glucose-1-phosphate drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Metabolic
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing